🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Hypofractionated Radiotherapy for Thymic Epithelial Tumors

RecruitingNAAges 18 Years - 75 YearsAllRongrong Zhou
NCT06692062 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if hypofractionated radiotherapy works to shorten the treatment time without increasing the side effects in patients of thymic epithelial tumors. The main questions it aims to answer are: * Does Hypofractionated radiotherapy provide better results? * Can hypofractionated radiotherapy reduce toxic and side effects compared with conventional radiotherapy? Researchers will compare the efficacy and safety of hypofractionated radiotherapy after thymic tumor surgery. Participants will: * Receive hypofractionated radiotherapy or conventional radiotherapy * Visit the hospital regularly once every 12 weeks for checkups and tests

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients must provide written informed consent. 2. 18 years old ≤ age \<75 years old. 3. Thymoma confirmed by pathology: type A, type AB, type B1, type B2, type B3. Thymic carcinoma. Patients with previous thymectomy were required to have complete surgical related data. 4. Masaoka⁃Koga ⁃ stage Ⅰ-Ⅲ 5. ECOG performance status 0-2. 6. Expected survival time \> 1 year. 7. Participants of childbearing age must agree to use effective contraception during the trial; In women of childbearing age, a serum or urine pregnancy test must be negative. 8. Patients who are not lactating. 9. Sufficient bone marrow reserve and good function of important organs. Exclusion Criteria: 1. patients with prior thoracic radiotherapy; 2. diseases not suitable for radiotherapy, such as recent myocardial infarction, active congestive heart failure; 3. Uncontrolled infectious disease or other serious medical or mental illness that may interfere with care 4. Patients with other malignant tumors that are not under stable control; 5. Known history of mental illness, substance abuse, alcohol or drug abuse. 6. Other conditions deemed unsuitable for enrollment by the attending physician.
💊

What it tests

  • Hypofractionated Radiation Therapy
📍

Where

1 site
Xiangya Hospital, Central South University
Changsha, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy